Half-year report · Q2
3937.TEDINET S100UMD4
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥591m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥541m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥936m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥526m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥7.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥651m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥727m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥504m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥39m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥273m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥221m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥57m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥155m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.87 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.73 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.57 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.81 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.15 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.1 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥190m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥15m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥240m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥847m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥841m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥542m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥170m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥477m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 1313900 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1085 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 645500 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0533 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 408500 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0337 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 197200 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0162 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 157371 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0130 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 156800 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0129 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 147827 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 140700 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0116 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 119200 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0098 | |
| Number of shares held | CurrentQuarterInstant | 8094338 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6688 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 126600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 120940 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 12094000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 8600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 12229200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 120940 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 126600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 126600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0104 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 126600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 126600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0104 | |
| Cash and deposits | Prior1YearInstant | 4026101000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 4562851000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 1417558000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 1356890000 | JPY |
| Other ca | Prior1YearInstant | 235096000 | JPY |
| Other ca | CurrentQuarterInstant | 205395000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -18581000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -17781000 | JPY |
| Current assets | Prior1YearInstant | 5660175000 | JPY |
| Current assets | CurrentQuarterInstant | 6107355000 | JPY |
| Property plant and equipment | Prior1YearInstant | 140347000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 121463000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |